Model Integration and Configuration for Bispecific Antibody

Data Characteristics

Bispecific antibody pharmacovigilance data originates from clinical trial reports, real-world studies, post-marketing surveillance databases (e.g., FDA Adverse Event Reporting System, FAERS; European Medicines Agency EudraVigilance), and literature reviews. Data updates are frequent, especially during initial market release or when new clinical studies are published. Document structures typically include clinical study protocols, case report forms (CRFs), adverse event (AE) report forms, and clinical study reports (CSRs). Fields include patient demographics, medical history, and comorbidities. They also detail the bispecific antibody's administration route, dosage, dosing cycle, adverse event onset time, severity, outcome, drug-relatedness assessment, and specific immunogenicity data. Dosage units are typically milligrams (mg) or milligrams per kilogram (mg/kg). Time units include days, weeks, and months. Adverse event severity is classified according to CTCAE (Common Terminology Criteria for Adverse Events) grades.

Constraints on Model Integration and Configuration

Diverse and frequently updated bispecific antibody data requires the model to support multi-source data integration and dynamic knowledge updates. For example, the model needs to support regular data pulls from databases like FAERS. Complex document structures, including unstructured text reports and structured tabular data, demand robust text parsing and multimodal data processing capabilities during data preprocessing to accurately extract adverse event information. Specific immunogenicity data involves complex biological concepts and specialized terminology, requiring deeper domain knowledge understanding from the model. This necessitates configuring specialized domain dictionaries and ontologies. Adverse event severity and relatedness assessments rely on standardized medical terminology and coding systems. Model configuration must ensure correct mapping of these codes to prevent information loss or misinterpretation. High-frequency data updates also mean the model needs to support incremental training or rapid fine-tuning to maintain knowledge base timeliness.

Configuration Settings

Configuration Item	Recommended Value	Rationale
`UPLOAD_FILE_MAX_SIZE`	`200 MB`	Clinical trial reports and safety summary reports can be large; ensure full upload.
`maxContext`	`8192 token`	Longer case reports and adverse event descriptions require a larger context window for comprehensive understanding.
`Chunk size` (Segment Length)	`800–1200 characters` (characters)	Balances semantic completeness and segment size, accommodating longer descriptive texts in adverse event reports.
`Recall count` (Recall Count)	`Top 10 entries` (top 10)	Ensures recall of sufficient relevant adverse event cases and immunogenicity data for analysis.
`Similarity threshold` (Similarity Threshold)	Calibrate by actual measurement	Optimize for semantic similarity of bispecific antibody-related adverse events to reduce false positives.
`Rerank result count` (Rerank Return Count)	`Top 5 entries` (top 5)	Prioritize displaying the most relevant key adverse event information and safety signals for the query.

Common Configuration Errors

Key adverse event severity or relatedness assessment fields are empty in model output. This occurs when CTCAE grade fields are not correctly parsed or mapped during data preprocessing, preventing the model from obtaining valid information.
When integrating external databases like FAERS, system logs show 401 Unauthorized or 403 Forbidden. This is often due to incorrect oneapi token configuration or insufficient API key permissions, leading to failed access to external data interfaces.
The model provides inaccurate or missing recall information when processing adverse events for newly launched bispecific antibodies. This happens when the knowledge base is not updated in time, lacking the latest safety data for the drug, resulting in outdated model knowledge.

Verification Steps

Upload a clinical trial report containing complete adverse event descriptions and CTCAE grades. Check if the model accurately extracts and structures the adverse event name, severity, and relatedness.
Query a known bispecific antibody drug through the FastGPT platform and ask about its specific immunogenicity adverse reactions. Verify if the information returned by the model aligns with the latest medical literature or database records.
Simulate a data synchronization operation from an external database (e.g., FAERS). Check system logs for records of successful data retrieval and import. Randomly select a few records for content comparison.

Note: The values provided are common starting points. Measure them against your own samples for optimal performance.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.